199 related articles for article (PubMed ID: 37939448)
1. miRNAs and exosomal miRNAs in lung cancer: New emerging players in tumor progression and therapy response.
Hashemi M; Khosroshahi EM; Chegini MK; Abedi M; Matinahmadi A; Hosnarody YSD; Rezaei M; Saghari Y; Fattah E; Abdi S; Entezari M; Nabavi N; Rashidi M; Raesi R; Taheriazam A
Pathol Res Pract; 2023 Nov; 251():154906. PubMed ID: 37939448
[TBL] [Abstract][Full Text] [Related]
2. Extracellular Vesicle (EVs) Associated Non-Coding RNAs in Lung Cancer and Therapeutics.
Paramanantham A; Asfiya R; Das S; McCully G; Srivastava A
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362424
[TBL] [Abstract][Full Text] [Related]
3. Exosomal miRNAs as biomarkers for diagnostic and prognostic in lung cancer.
Wu J; Shen Z
Cancer Med; 2020 Oct; 9(19):6909-6922. PubMed ID: 32779402
[TBL] [Abstract][Full Text] [Related]
4. Role of exosomal microRNAs in lung cancer biology and clinical applications.
Hu C; Meiners S; Lukas C; Stathopoulos GT; Chen J
Cell Prolif; 2020 Jun; 53(6):e12828. PubMed ID: 32391938
[TBL] [Abstract][Full Text] [Related]
5. Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT.
Zhang X; Sai B; Wang F; Wang L; Wang Y; Zheng L; Li G; Tang J; Xiang J
Mol Cancer; 2019 Mar; 18(1):40. PubMed ID: 30866952
[TBL] [Abstract][Full Text] [Related]
6. Spotlight on Exosomal Non-Coding RNAs in Breast Cancer: An In Silico Analysis to Identify Potential lncRNA/circRNA-miRNA-Target Axis.
Ashekyan O; Abdallah S; Shoukari AA; Chamandi G; Choubassy H; Itani ARS; Alwan N; Nasr R
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955480
[TBL] [Abstract][Full Text] [Related]
7. Acidic Microenvironment Up-Regulates Exosomal miR-21 and miR-10b in Early-Stage Hepatocellular Carcinoma to Promote Cancer Cell Proliferation and Metastasis.
Tian XP; Wang CY; Jin XH; Li M; Wang FW; Huang WJ; Yun JP; Xu RH; Cai QQ; Xie D
Theranostics; 2019; 9(7):1965-1979. PubMed ID: 31037150
[No Abstract] [Full Text] [Related]
8. Long non-coding RNAs and exosomal lncRNAs: Potential functions in lung cancer progression, drug resistance and tumor microenvironment remodeling.
Entezari M; Ghanbarirad M; Taheriazam A; Sadrkhanloo M; Zabolian A; Goharrizi MASB; Hushmandi K; Aref AR; Ashrafizadeh M; Zarrabi A; Nabavi N; Rabiee N; Hashemi M; Samarghandian S
Biomed Pharmacother; 2022 Jun; 150():112963. PubMed ID: 35468579
[TBL] [Abstract][Full Text] [Related]
9. Crosstalk of Exosomal Non-Coding RNAs in The Tumor Microenvironment: Novel Frontiers.
Jia Z; Jia J; Yao L; Li Z
Front Immunol; 2022; 13():900155. PubMed ID: 35663957
[TBL] [Abstract][Full Text] [Related]
10. Exosomal MicroRNAs as Mediators of Cellular Interactions Between Cancer Cells and Macrophages.
Kwon Y; Kim M; Kim Y; Jung HS; Jeoung D
Front Immunol; 2020; 11():1167. PubMed ID: 32595638
[TBL] [Abstract][Full Text] [Related]
11. miRNA and cancer; computational and experimental approaches.
Tutar Y
Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
[TBL] [Abstract][Full Text] [Related]
12. Effect of exosomal miRNA on cancer biology and clinical applications.
Sun Z; Shi K; Yang S; Liu J; Zhou Q; Wang G; Song J; Li Z; Zhang Z; Yuan W
Mol Cancer; 2018 Oct; 17(1):147. PubMed ID: 30309355
[TBL] [Abstract][Full Text] [Related]
13. Exosomal miRNAs as biomarkers of recurrent lung cancer.
Munagala R; Aqil F; Gupta RC
Tumour Biol; 2016 Aug; 37(8):10703-14. PubMed ID: 26867772
[TBL] [Abstract][Full Text] [Related]
14. The Role of Exo-miRNAs in Cancer: A Focus on Therapeutic and Diagnostic Applications.
Ingenito F; Roscigno G; Affinito A; Nuzzo S; Scognamiglio I; Quintavalle C; Condorelli G
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31546654
[TBL] [Abstract][Full Text] [Related]
15. Exosomal microRNAs and long noncoding RNAs: Novel mediators of drug resistance in lung cancer.
Taghvimi S; Vakili O; Soltani Fard E; Khatami SH; Karami N; Taheri-Anganeh M; Salehi M; Negahdari B; Ghasemi H; Movahedpour A
J Cell Physiol; 2022 Apr; 237(4):2095-2106. PubMed ID: 35128660
[TBL] [Abstract][Full Text] [Related]
16. Exosomal miR-133a-3p promotes the growth and metastasis of lung cancer cells following incomplete microwave ablation.
Yang X; Yu F; Huang G; Ni Y; Zhang T; Zou Z; Meng M
Int J Hyperthermia; 2023; 40(1):2190065. PubMed ID: 37031959
[TBL] [Abstract][Full Text] [Related]
17. Role of exosomal non-coding RNAs from tumor cells and tumor-associated macrophages in the tumor microenvironment.
Xu Z; Chen Y; Ma L; Chen Y; Liu J; Guo Y; Yu T; Zhang L; Zhu L; Shu Y
Mol Ther; 2022 Oct; 30(10):3133-3154. PubMed ID: 35405312
[TBL] [Abstract][Full Text] [Related]
18. Non-coding RNAs and macrophage interaction in tumor progression.
Entezari M; Sadrkhanloo M; Rashidi M; Asnaf SE; Taheriazam A; Hashemi M; Ashrafizadeh M; Zarrabi A; Rabiee N; Hushmandi K; Mirzaei S; Sethi G
Crit Rev Oncol Hematol; 2022 May; 173():103680. PubMed ID: 35405273
[TBL] [Abstract][Full Text] [Related]
19. Exosomal microRNAs mediating crosstalk between cancer cells and cancer-associated fibroblasts in the tumor microenvironment.
Wang Y; Liang H; Zheng J
Pathol Res Pract; 2022 Nov; 239():154159. PubMed ID: 36244248
[TBL] [Abstract][Full Text] [Related]
20. MiRNAs and LncRNAs: Dual Roles in TGF-β Signaling-Regulated Metastasis in Lung Cancer.
Lai XN; Li J; Tang LB; Chen WT; Zhang L; Xiong LX
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32054031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
